Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.01
Delayed Data
As of Feb 12
 -0.06 / -1.47%
Today’s Change
3.61
Today|||52-Week Range
11.15
-34.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues-571.0K248.0K1.9M1.4M
 
 
 
 
 
Cost of Goods Sold27.0K--178.0K123.0K
 
 
 
 
Depreciation And Amortization126.0K132.0K129.0K137.0K
 
 
 
 
 
 
Operating ExpensesGross Income-724.0K--1.6M1.1M
 
 
 
 
General Expenses10.0M10.1M12.5M11.4M
 
 
 
 
 
Research And Development6.2M6.5M6.5M6.9M
 
 
 
 
 
Total Operating Expenses10.2M10.2M12.8M11.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.8M-10.0M-10.9M-10.2M
 
 
 
 
 
Extraordinary Credit--0.000.00200.0K
 
 
Extraordinary Charge-2.2M-300.0K-800.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.9M-10.3M-11.7M-10.0M
 
 
 
 
 
Income Taxes-761.0K0.000.000.00
 
 
Net Income-12.2M-10.3M-11.7M-10.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.6M69.6M69.6M69.7M
 
 
 
 
 
Shares To Calculate EPS Diluted69.6M69.6M69.6M69.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.15-$0.17-$0.14
 
 
 
 
 
EPS Diluted-$0.18-$0.15-$0.17-$0.14